Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

by | May 28, 2026 | Stock Market

That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.

Article Attribution | Read More at Article Source